These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 16817763)

  • 41. Human adenovirus-vectored foot-and-mouth disease vaccines: establishment of a vaccine product profile through in vitro testing.
    Brake DA; McIlhaney M; Miller T; Christianson K; Keene A; Lohnas G; Purcell C; Neilan J; Schutta C; Barrera J; Burrage T; Brough DE; Butman BT
    Dev Biol (Basel); 2012; 134():123-33. PubMed ID: 22888605
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alpha interferon is a powerful adjuvant for a recombinant protein vaccine against foot-and-mouth disease virus in swine, and an effective stimulus of in vivo immune response.
    Cheng G; Zhao X; Yan W; Wang W; Zuo X; Huang K; Liu Y; Chen J; Wang J; Cong W; Liu M; Gao H; Chen J; Lu Y; Zheng Z
    Vaccine; 2007 Jul; 25(28):5199-208. PubMed ID: 17555848
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Establishment of indirect ELISA diagnose based on the VP1 structural protein of foot-and-mouth disease virus (FMDV) in pigs].
    Wang GH; Du JZ; Cong GZ; Shao JJ; Lin T; Xue HW; Chang HY; Xie QG
    Sheng Wu Gong Cheng Xue Bao; 2007 Sep; 23(5):961-6. PubMed ID: 18051883
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adenovirus-vectored type Asia1 foot-and-mouth disease virus (FMDV) capsid proteins as a vehicle to display a conserved, neutralising epitope of type O FMDV.
    Chai Z; Wang H; Zhou G; Yang D; Wang J; Yu L
    J Virol Methods; 2013 Mar; 188(1-2):175-82. PubMed ID: 22981982
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunogenicity of a recombinant fusion protein of tandem repeat epitopes of foot-and-mouth disease virus type Asia 1 for guinea pigs.
    Zhang Q; Yang YQ; Zhang ZY; Li L; Yan WY; Jiang WJ; Xin AG; Lei CX; Zheng ZX
    Acta Virol; 2002; 46(1):1-9. PubMed ID: 12199204
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vesicular Stomatitis Virus glycoprotein G carrying a tandem dimer of Foot and Mouth Disease Virus antigenic site A can be used as DNA and peptide vaccine for cattle.
    Capozzo AV; Wilda M; Bucafusco D; de los Ángeles Lavoria M; Franco-Mahecha OL; Mansilla FC; Pérez-Filgueira DM; Grigera PR
    Antiviral Res; 2011 Nov; 92(2):219-27. PubMed ID: 21889542
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunogenic evaluation of FMD virus immuno-dominant epitopes coupled with IL-2/FcIgG in BALB/c mice.
    Doosti M; Nassiri M; Nasiri K; Tahmoorespur M; Zibaee S
    Microb Pathog; 2019 Jul; 132():30-37. PubMed ID: 31004723
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Safety profile of a replication-deficient human adenovirus-vectored foot-and-mouth disease virus serotype A24 subunit vaccine in cattle.
    Barrera J; Brake DA; Kamicker BJ; Purcell C; Kaptur R; Schieber T; Lechtenberg K; Miller TD; Ettyreddy D; Brough DE; Butman BT; Colby M; Neilan JG
    Transbound Emerg Dis; 2018 Apr; 65(2):447-455. PubMed ID: 29076657
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunogenicity of the epitope of the foot-and-mouth disease virus fused with a hepatitis B core protein as expressed in transgenic tobacco.
    Huang Y; Liang W; Wang Y; Zhou Z; Pan A; Yang X; Huang C; Chen J; Zhang D
    Viral Immunol; 2005; 18(4):668-77. PubMed ID: 16359233
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate.
    Mayr GA; Chinsangaram J; Grubman MJ
    Virology; 1999 Oct; 263(2):496-506. PubMed ID: 10544121
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CpG oligodeoxynucleotide and montanide ISA 206 adjuvant combination augments the immune responses of a recombinant FMDV vaccine in cattle.
    Ren J; Yang L; Xu H; Zhang Y; Wan M; Liu G; Zhao L; Wang L; Yu Y
    Vaccine; 2011 Oct; 29(45):7960-5. PubMed ID: 21872635
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of synthetic peptide candidate vaccines against serotype-A foot-and-mouth disease virus in cattle.
    Zhang Z; Pan L; Ding Y; Zhou P; Lv J; Chen H; Fang Y; Liu X; Chang H; Zhang J; Shao J; Lin T; Zhao F; Zhang Y; Wang Y
    Appl Microbiol Biotechnol; 2015 Feb; 99(3):1389-98. PubMed ID: 25381487
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Promising multiple-epitope recombinant vaccine against foot-and-mouth disease virus type O in swine.
    Shao JJ; Wong CK; Lin T; Lee SK; Cong GZ; Sin FW; Du JZ; Gao SD; Liu XT; Cai XP; Xie Y; Chang HY; Liu JX
    Clin Vaccine Immunol; 2011 Jan; 18(1):143-9. PubMed ID: 21084463
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Fusion expression of O type foot-and-mouth diseases virus VP1 gene and HSP70 gene and induction of immune responses in mice].
    Su CX; Duan XG; Wang XQ; Ren XF; Cao RB; Zhou B; Chen PY
    Sheng Wu Gong Cheng Xue Bao; 2006 Sep; 22(5):733-6. PubMed ID: 17037194
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Protective immune responses against foot-and-mouth disease virus by vaccination with a DNA vaccine expressing virus-like particles.
    Jin H; Xiao W; Xiao C; Yu Y; Kang Y; Du X; Wei X; Wang B
    Viral Immunol; 2007 Sep; 20(3):429-40. PubMed ID: 17931113
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cloning and expression of a novel synthetic gene containing VP1 and 3A in Bacillus subtilis as a vaccine candidate against foot-and-mouth disease virus.
    Aghaei A; Moghbeli M; Kargar M; Nazarian S; Kafilzadeh F
    Biologicals; 2019 Jul; 60():55-59. PubMed ID: 31103374
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enhanced immune response of DNA vaccine (VP1-pCDNA) adsorbed on cationic PLG for foot and mouth disease in guinea pigs.
    Choudary S; Ravikumar P; Ashok Kumar C; Suryanarayana VV; Reddy GR
    Virus Genes; 2008 Aug; 37(1):81-7. PubMed ID: 18516668
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Custom-engineered chimeric foot-and-mouth disease vaccine elicits protective immune responses in pigs.
    Blignaut B; Visser N; Theron J; Rieder E; Maree FF
    J Gen Virol; 2011 Apr; 92(Pt 4):849-59. PubMed ID: 21177923
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sindbis virus replicase-based DNA vaccine construct encoding FMDV-specific multivalent epitope gene: studies on its immune responses in guinea pigs.
    Dar PA; Ganesh K; Nagarajan G; Sarika S; Reddy GR; Suryanarayana VV
    Scand J Immunol; 2012 Oct; 76(4):345-53. PubMed ID: 22702835
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chimeric foot-and-mouth disease viruses: evaluation of their efficacy as potential marker vaccines in cattle.
    Fowler VL; Paton DJ; Rieder E; Barnett PV
    Vaccine; 2008 Apr; 26(16):1982-9. PubMed ID: 18342409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.